Sergio Casas Tintó

Starting Cancer Neuroscience meeting! @helloeacr.bsky.social

We are pleased to announce that the 2nd DrosoSpain meeting #DrosoSpain2026 will take place in San Joan de Alicante from the 9th to the 11th of April 2026 #savethedate

Reaffirming the value of model organisms in training scientific minds - Nature Cell Biology As biomedical research prioritizes human models and translational promise, classic model organisms are increasingly dismissed. Here we argue that they have a lasting value, both in enabling discovery and in cultivating scientific thinking, by training researchers in systems reasoning, integrative thinking and independent inquiry.

Model organisms, in particular non-mammalian model organisms, such as yeast, Caenorhabditis elegans, #Drosophila and zebrafish, have long stood at the centre of biological discovery www.nature.com/articles/s41...

Probando nuevos equipos de @leicamicrosystems.bsky.social en el @isciiisalud.bsky.social

Do you have some cool results to present to the #Drosophila community at #EDRC2025 ? Please do not forget that abstract submissions are opened until the 28th of May edrc2025alicante.com/abstracts/

Tubefiller 300 to prepare #Drosohila food vials

To the Drosophila community: please cite the original source and support the outstanding contribution of public databases and stocks collections.

Ideally, we'd like authors to cite a recent FlyBase publication. There's a blue box with the text "Citing FlyBase' on our homepage that takes you a page detailing how to cite us wiki.flybase.org/wiki/FlyBase...

VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context Glioblastoma (GB) is an incurable cancer of the brain, and there is an urgent need to identify effective treatments. This may be achieved by either id…

Using human GB cells, #Drosophila GB models & mice GB xenografts, we show that VP3.15 blocks tumor progression—but only in PTEN wild-type contexts. Precision medicine in action! 🏥🔬 www.sciencedirect.com/science/arti...

💊 Can a multiple sclerosis drug help fight brain cancer? 🧬 Our study shows that VP3.15 slows glioblastoma by altering immune cells & reducing blood vessel formation. A promising new approach! #CancerTherapy #MedicalResearch #CancerBiology

🧠 Glioblastoma is a deadly brain cancer. Our research identifies VP3.15, a molecule that reduces tumor growth—but only in patients with a specific genetic profile (PTEN+). A step toward personalized treatments! 💡 #BrainCancer #PrecisionMedicine #Glioblastoma

Y alguien que sabe mucho de esto es @sergiocasastinto.bsky.social que ayer volvió a demostrarnos la versatilidad de #Drosophila y la importancia de este modelo para dar con nuevos tratamientos para #enfermedadesraras y #cancer

El trabajo de su laboratorio es increíble! 🧠🪰

Really happy to announce that the final version of our work about "Adult neurogenesis through glial transdifferentiation" in drosophila is finally out in @elife.bsky.social elifesciences.org/reviewed-prepr…
Congrats team! @sergiocasastinto.bsky.social

Final version of this work in collaboration with Maria Losada in @elife.bsky.social: Adult neurogenesis through glial transdifferentiation in a CNS injury paradigm doi.org/10.7554/eLif...

Extremely honored to receive this award from a Society I value, full of colleagues and friends. Dev Bio is well and alive, and we're proof of it! Dev Bio FTW